Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGL NASDAQ:CSTL NASDAQ:DCGO NASDAQ:FLGT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLAgilon Health$1.28+0.4%$1.75$0.71▼$6.08$530.46M0.1223.02 million shs3.91 million shsCSTLCastle Biosciences$24.01+2.3%$19.09$14.59▼$35.84$696.49M1.07747,453 shs518,805 shsDCGODocGo$1.56-4.3%$1.54$1.23▼$5.68$152.58M0.97487,863 shs425,897 shsFLGTFulgent Genetics$22.17+0.6%$19.86$14.57▼$23.56$678.60M0.81270,210 shs348,546 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLAgilon Health0.00%-3.77%-24.78%-43.46%-68.75%CSTLCastle Biosciences0.00%+15.21%+63.89%+47.57%-19.08%DCGODocGo0.00%-9.30%+17.29%+4.70%-58.73%FLGTFulgent Genetics0.00%+1.84%+19.64%+7.26%-1.73%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLAgilon Health2.427 of 5 stars4.12.00.00.02.70.00.6CSTLCastle Biosciences2.5323 of 5 stars3.43.00.00.03.51.70.0DCGODocGo1.9284 of 5 stars3.33.00.00.01.70.80.6FLGTFulgent Genetics3.476 of 5 stars2.31.00.04.12.73.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLAgilon Health 2.11Hold$3.07140.90% UpsideCSTLCastle Biosciences 2.89Moderate Buy$37.0054.10% UpsideDCGODocGo 2.50Moderate Buy$3.59130.13% UpsideFLGTFulgent Genetics 2.67Moderate Buy$25.3314.27% UpsideCurrent Analyst Ratings BreakdownLatest DCGO, FLGT, CSTL, and AGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/27/2025CSTLCastle BiosciencesZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/21/2025DCGODocGoCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$1.45 ➝ $1.608/20/2025AGLAgilon HealthSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$4.00 ➝ $1.408/15/2025AGLAgilon HealthJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$2.40 ➝ $1.108/14/2025AGLAgilon HealthRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$5.00 ➝ $1.008/6/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$3.00 ➝ $1.508/6/2025AGLAgilon HealthBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$4.00 ➝ $1.508/5/2025FLGTFulgent GeneticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$20.00 ➝ $30.008/4/2025FLGTFulgent GeneticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Neutral$23.00 ➝ $21.007/9/2025AGLAgilon HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$5.00 ➝ $3.00(Data available from 9/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLAgilon Health$6.06B0.09N/AN/A$1.14 per share1.12CSTLCastle Biosciences$332.07M2.10$0.98 per share24.40$16.28 per share1.47DCGODocGo$616.55M0.25$0.42 per share3.69$3.09 per share0.50FLGTFulgent Genetics$283.47M2.39N/AN/A$36.92 per share0.60Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLAgilon Health-$260.15M-$0.77N/AN/AN/A-5.35%-66.76%-17.47%11/6/2025 (Estimated)CSTLCastle Biosciences$18.25M-$0.35N/AN/AN/A-2.73%2.37%2.03%11/3/2025 (Estimated)DCGODocGo$19.99M-$0.190.0019.50N/A-4.20%-3.26%-2.24%11/6/2025 (Estimated)FLGTFulgent Genetics-$42.71M-$1.66N/AN/AN/A-16.83%-2.26%-2.10%11/14/2025 (Estimated)Latest DCGO, FLGT, CSTL, and AGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025DCGODocGo-$0.06-$0.11-$0.05-$0.11$77.58 million$80.42 million8/4/2025Q2 2025AGLAgilon Health-$0.11-$0.25-$0.14-$0.25$1.47 billion$1.39 billion8/4/2025Q2 2025CSTLCastle Biosciences-$0.51$0.15+$0.66$0.15$71.53 million$86.18 million8/1/2025Q2 2025FLGTFulgent Genetics-$0.23$0.07+$0.30-$0.62$76.21 million$81.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLAgilon HealthN/AN/AN/AN/AN/ACSTLCastle BiosciencesN/AN/AN/AN/AN/ADCGODocGoN/AN/AN/AN/AN/AFLGTFulgent GeneticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLAgilon HealthN/A1.161.16CSTLCastle Biosciences0.026.856.69DCGODocGoN/A2.362.36FLGTFulgent GeneticsN/A6.016.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLAgilon HealthN/ACSTLCastle Biosciences92.60%DCGODocGo56.44%FLGTFulgent Genetics48.06%Insider OwnershipCompanyInsider OwnershipAGLAgilon Health3.57%CSTLCastle Biosciences7.20%DCGODocGo3.80%FLGTFulgent Genetics33.11%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLAgilon Health1,076414.42 million399.63 millionNot OptionableCSTLCastle Biosciences54029.01 million26.92 millionOptionableDCGODocGo4,40797.81 million94.09 millionOptionableFLGTFulgent Genetics1,31330.61 million20.47 millionOptionableDCGO, FLGT, CSTL, and AGL HeadlinesRecent News About These CompaniesAlphaQuest LLC Sells 20,112 Shares of Fulgent Genetics, Inc. $FLGTSeptember 1 at 4:10 AM | marketbeat.comVanguard Group Inc. Lowers Stake in Fulgent Genetics, Inc. $FLGTSeptember 1 at 3:12 AM | marketbeat.comJump Financial LLC Raises Position in Fulgent Genetics, Inc. $FLGTAugust 31 at 4:34 AM | marketbeat.comCharles Schwab Investment Management Inc. Boosts Stock Position in Fulgent Genetics, Inc. $FLGTAugust 31 at 3:13 AM | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Insider Sells $20,255.64 in StockAugust 29 at 8:06 AM | insidertrades.comInsider Selling: Fulgent Genetics (NASDAQ:FLGT) Insider Sells 548 Shares of StockAugust 27, 2025 | insidertrades.comQuantbot Technologies LP Acquires 33,828 Shares of Fulgent Genetics, Inc. $FLGTAugust 27, 2025 | marketbeat.comFulgent Genetics, Inc. $FLGT Shares Bought by Deutsche Bank AGAugust 19, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)August 15, 2025 | marketbeat.comXTX Topco Ltd Takes $324,000 Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)August 11, 2025 | marketbeat.comFulgent Genetics (FLGT) Receives a Hold from Piper SandlerAugust 9, 2025 | theglobeandmail.comFulgent Genetics (NASDAQ:FLGT) Shares Up 9.3% - Here's WhyAugust 6, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Raised to "Buy" at UBS GroupAugust 6, 2025 | marketbeat.comUBS Upgrades Fulgent Genetics (FLGT)August 6, 2025 | msn.comFulgent Genetics (NASDAQ:FLGT) Shares Down 3.4% Following Analyst DowngradeAugust 5, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Price Target Lowered to $21.00 at Piper SandlerAugust 5, 2025 | marketbeat.comFulgent Genetics’ Earnings Call Highlights Growth and OptimismAugust 4, 2025 | theglobeandmail.comFulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings ResultsAugust 3, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Shares Gap Up After Earnings BeatAugust 2, 2025 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call TranscriptAugust 2, 2025 | insidermonkey.comFulgent Genetics (NASDAQ:FLGT) Updates FY 2025 Earnings GuidanceAugust 2, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDCGO, FLGT, CSTL, and AGL Company DescriptionsAgilon Health NYSE:AGL$1.27 +0.01 (+0.39%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$1.28 +0.01 (+0.39%) As of 08/29/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Castle Biosciences NASDAQ:CSTL$24.01 +0.55 (+2.34%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$24.01 0.00 (0.00%) As of 08/29/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.DocGo NASDAQ:DCGO$1.56 -0.07 (-4.29%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.56 -0.01 (-0.32%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Fulgent Genetics NASDAQ:FLGT$22.17 +0.14 (+0.64%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$22.18 +0.01 (+0.05%) As of 08/29/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
